Discover trends, market shifts, and competitive outlooks for the targeted therapy industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has The Targeted Therapy Market Size Shifted, And What Is the Outlook Through 2034?#_x000D_

The market size of targeted therapy has seen a solid expansion in the past few years. It is projected to escalate from $103.84 billion in 2024 to an impressive $111.47 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.3%. Factors such as progress in molecular biology, rising cancer rates, the shift towards personalized medicine, FDA certifications, and regulatory backing fueled the growth during the historic period._x000D_

_x000D_

The market size for targeted therapy is anticipated to experience robust growth in the approaching years. The market is predicted to expand to $151.48 billion in 2029, with a compound annual growth rate (CAGR) of 8.0%. Factors contributing to this projected growth during the forecast period include the expansion of oncology research, the surging need for precision medicine, the emergence of immunotherapies, escalating investment in biopharmaceuticals, and increased patient awareness and advocacy. Key trends to watch during the forecast period include the integration of artificial intelligence (AI) into drug discovery, increased patient advocacy and involvement in treatment decisions, the growth of companion diagnostics, regulatory backing for accelerated approvals, as well as rising investment in biotechnology and pharmaceuticals._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=9129&type=smp_x000D_

_x000D_

#What Are the Core Market Drivers Propelling Growth in the Targeted Therapy Industry?#_x000D_

The surge in cancer incidents is predicted to stimulate the expansion of the targeted therapy market in the future. Cancer refers to diseases where abnormal cells can proliferate uncontrollably and invade neighboring tissues. Targeted therapy can hinder the triggers that stimulate the multiplication of cancer cells or instruct the cancer cells to eliminate themselves. This treatment uses drugs that specifically aim at the genes and proteins which facilitate the expansion and survival of cancer cells, thereby heightening its demand. For example, the American Cancer Society, a nonprofit cancer advocacy organization based in the US, reported in January 2024 that the cancer cases escalated to 2,001,140 from 1,958,310 in 2023, suggesting a growth rate of 2.19%. Hence, the escalating occurrence of cancer will fuel the advancement of the targeted therapy market._x000D_

_x000D_

#How Is the Targeted Therapy Market Segmented?#_x000D_

The targeted therapy market covered in this report is segmented –_x000D_

_x000D_

1) By Type: Small Molecule Medicines, Monoclonal Antibodies_x000D_

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies_x000D_

3) By Application: Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Renal Cancer, Other Applications_x000D_

_x000D_

Subsegments:_x000D_

1) By Small Molecule Medicines: Tyrosine Kinase Inhibitors (TKIs), Proteasome Inhibitors, Phosphatidylinositol 3-Kinase (PI3K) Inhibitors, Other Small Molecule Therapies_x000D_

2) By Monoclonal Antibodies: Immune Checkpoint Inhibitors, Antibody-Drug Conjugates (ADCs), Cytokine Blockers, Other Monoclonal Antibodies_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=9129&type=smp_x000D_

_x000D_

#Which Regions Are Driving the Next Phase of the Targeted Therapy Market Growth?#_x000D_

North America was the largest region in the targeted therapy market in 2024. The regions covered in the targeted therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Key Market Trends and Innovations Are Shaping the Future of the Targeted Therapy Industry?#_x000D_

In an effort to solidify their dominance in the targeted therapy market, leading corporations are investing in the creation of innovative technological solutions. In March 2022, for instance, the multinational pharmaceutical corporation based in Switzerland, Novartis AG, introduced Pluvicto, a product that received approval from the US Food and Drug Administration (FDA). Notably, Pluvicto marks the first FDA-sanctioned targeted radioligand therapy (RLT) for selected patients suffering from mCRPC. It fuses a therapeutic radioisotope with a specific chemical (a radioactive particle), originating a variant of targeted cancer therapy which merges a therapeutic radioisotope and a targeted chemical. By adhering to circulating target cells including those of prostate cancer expressing the PSMA transmembrane protein, Pluvicto ensures that the radioisotope’s energy emissions harm these cells and others nearby, restricting replication and potentially causing cell death._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report_x000D_

_x000D_

#How Is the Targeted Therapy Market Defined and What Are Its Core Parameters?#_x000D_

Targeted therapy refers to a kind of cancer treatment that employs medications or other chemicals to attack particular molecules required for the survival and spread of cancer cells. It uses drugs to target specific genes and proteins that help cancer cells survive and grow._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9129_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model